Generali Asset Management SPA SGR acquired a new position in Corteva, Inc. (NYSE:CTVA – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm acquired 29,123 shares of the company’s stock, valued at approximately $1,659,000.
Several other large investors have also recently bought and sold shares of CTVA. Raymond James Financial Inc. purchased a new position in Corteva in the fourth quarter worth $161,052,000. Franklin Resources Inc. grew its holdings in Corteva by 6.1% in the third quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company’s stock valued at $860,746,000 after purchasing an additional 856,007 shares during the last quarter. State Street Corp grew its holdings in Corteva by 2.3% in the third quarter. State Street Corp now owns 34,290,086 shares of the company’s stock valued at $2,015,914,000 after purchasing an additional 768,519 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Corteva by 176.0% in the third quarter. BNP Paribas Financial Markets now owns 934,748 shares of the company’s stock valued at $54,954,000 after purchasing an additional 596,073 shares during the last quarter. Finally, Dearborn Partners LLC grew its holdings in Corteva by 5,353.8% in the fourth quarter. Dearborn Partners LLC now owns 547,230 shares of the company’s stock valued at $31,170,000 after purchasing an additional 537,196 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Wall Street Analyst Weigh In
CTVA has been the topic of several research reports. BNP Paribas raised Corteva to a “hold” rating in a report on Monday, February 10th. Royal Bank of Canada upped their target price on Corteva from $72.00 to $73.00 and gave the company an “outperform” rating in a report on Friday, February 7th. Citigroup upped their target price on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Barclays upped their target price on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a report on Tuesday, January 21st. Finally, Bank of America increased their price objective on Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $68.00.
Corteva Stock Down 1.0 %
Shares of NYSE:CTVA opened at $61.86 on Friday. The stock’s 50-day moving average price is $62.34 and its two-hundred day moving average price is $59.81. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The firm has a market cap of $42.41 billion, a price-to-earnings ratio of 47.95, a PEG ratio of 1.68 and a beta of 0.79.
Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were issued a $0.17 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. Corteva’s dividend payout ratio (DPR) is 52.71%.
Insider Transactions at Corteva
In other news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This trade represents a 70.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.20% of the company’s stock.
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Recommended Stories
- Five stocks we like better than Corteva
- Dividend Payout Ratio Calculator
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- ETF Screener: Uses and Step-by-Step Guide
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.